Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson's disease

Bing Chen,Qian Zhang,Xiaoru Zhong,Xinwei Zhang,Xin Liu,Hongyang Wang,Fan Yang,Jingjing Zhang,Jingnan Huang,Yin-Kwan Wong,Piao Luo,Jigang Wang,Jichao Sun

DOI: https://doi.org/10.1186/s12964-024-01478-0

IF: 7.525

2024-01-31

Cell Communication and Signaling

Abstract:Parkinson's disease (PD), a chronic and severe neurodegenerative disease, is pathologically characterized by the selective loss of nigrostriatal dopaminergic neurons. Dopamine (DA), the neurotransmitter produced by dopaminergic neurons, and its metabolites can covalently modify proteins, and dysregulation of this process has been implicated in neuronal loss in PD. However, much remains unknown about the protein targets.

cell biology